Centessa Pharmaceuticals (NASDAQ:CNTA) is one of the 17 biotechnology stocks with more than 50% upside. On January 29, Danielle Brill from Truist Financial raised her price target on Centessa ...

Centessa Pharmaceuticals (NASDAQ:CNTA) is one of the promising stocks to buy under $50. On January 8, Truist analyst Danielle Brill raised the firm’s price target on Centessa to $33 from $30, while ...

Stock context and recent performance snapshot Centessa Pharmaceuticals (NasdaqGS:CNTA) has attracted attention after recent trading, with the stock last closing at $24.71. For investors, the key ...

Investors in Centessa Pharmaceuticals PLC (Symbol: CNTA) saw new options become available this week, for the July 2026 expiration. One of the key data points that goes into the price an option buyer ...

For over 30 years, CNTA has been serving the public. Founded in 1991, as a grass-roots organization, we remain the largest, citizens-based nonprofit organization in the U.S. focused on nuclear ...

Investors are always looking for stocks that are poised to beat at earnings season and Centessa Pharmaceuticals plc CNTA may be one such company. The firm has earnings coming up pretty soon, and ...

Centessa Pharmaceuticals plc (NASDAQ:CNTA) is one of the best 52-week high stocks to buy right now. On December 1, B. Riley boosted its price target on Centessa Pharmaceuticals plc (NASDAQ:CNTA) to ...

Citizens for Nuclear Technology Awareness , the area’s nonprofit organization for nuclear education, recently held its membership appreciation night and annual meeting on March 28. Sponsored by ...

Centessa Pharmaceuticals (NASDAQ:CNTA) is one of the best biotech stocks to invest in now. On June 16, Centessa Pharmaceuticals announced that the US FDA cleared its Investigational New Drug/IND ...